Skip to content

Penn Neurology – Division of Stroke and Vascular Neurology

  • About Penn Stroke
  • News and events
  • Donate
  • Our Research
  • Patient care
  • Vascular Neurology Fellowship Program
  • TCD MES tutorial
    • Introduction
    • Example Videos, Module 1
    • Example Videos, Module 2
  • What we’re reading
  • Quick Takes
  • Useful links
  • Internal
    • Phone Numbers
    • Protocols and Schedules
    • Research

WHAT WE’RE READING – JOURNAL CLUB

November 3, 2015July 28, 2016

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
Like Loading...

Related

Posted in: Uncategorized, What we're reading

Post navigation

 WHAT WE’RE READING – JOURNAL CLUB
WHAT WE’RE READING – JOURNAL CLUB 

Recent Posts

  • WHAT WE’RE READING- JOURNAL CLUB
  • Celebrating our fellows 100% board exam pass rate
  • Farewell to Dr. Scott Kasner
  • Dr. Donna Kurowski George receives AAN 2026 A.B. Baker Teacher Recognition Award
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • Welcome to our 2025 fellows
  • Congratulations to our 2025 graduating fellows!
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING-JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • WHAT WE’RE READING- JOURNAL CLUB
  • Cover image of Stroke Journal
Blog at WordPress.com.
  • Reblog
  • Subscribe Subscribed
    • Penn Neurology - Division of Stroke and Vascular Neurology
    • Already have a WordPress.com account? Log in now.
    • Penn Neurology - Division of Stroke and Vascular Neurology
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d